Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price
Apr 19
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedApr 18, 2024
DataAggregated Company Financials
Companies14
- 7D-0.4%
- 3M1.6%
- 1Y14.9%
- YTD-2.2%
In the last week, the Life Sciences industry is flat overall, with Syngene International standing out by going down 3.2%. The past year has been better, since the industry has gained 15% in that time. Looking forward, earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 19 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 28.9x | 76.4x | 8.4x |
| Sun, 17 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 29x | 71.3x | 7.9x |
| Tue, 13 Feb 2024 | ₹1.4t | ₹168.5b | ₹19.6b | 33.5x | 72.9x | 8.5x |
| Thu, 11 Jan 2024 | ₹1.4t | ₹155.9b | ₹18.1b | 23.8x | 79.2x | 9.2x |
| Sat, 09 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 23.2x | 75.1x | 8.7x |
| Mon, 06 Nov 2023 | ₹1.3t | ₹156.1b | ₹19.9b | 23.3x | 63.1x | 8x |
| Wed, 04 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.5x | 71.8x | 9.1x |
| Fri, 01 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.5x | 68.7x | 8.8x |
| Sun, 30 Jul 2023 | ₹1.4t | ₹158.1b | ₹23.2b | 31.1x | 60.9x | 8.9x |
| Tue, 27 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.9x | 57.1x | 8.4x |
| Thu, 25 May 2023 | ₹1.3t | ₹158.1b | ₹22.6b | 33x | 55.6x | 8x |
| Sat, 22 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 32.4x | 41.6x | 7.4x |
| Mon, 20 Mar 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 30.9x | 36.9x | 6.6x |
| Wed, 15 Feb 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 33.8x | 36.8x | 6.5x |
| Fri, 13 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 29.3x | 34.9x | 7.3x |
| Sun, 11 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30x | 34.5x | 7.2x |
| Tue, 08 Nov 2022 | ₹1.2t | ₹164.1b | ₹36.1b | 35.2x | 34.4x | 7.6x |
| Thu, 06 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.1x | 36.8x | 8.1x |
| Sat, 03 Sep 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 42.5x | 35.8x | 7.9x |
| Mon, 01 Aug 2022 | ₹1.3t | ₹159.0b | ₹34.4b | 34.4x | 38.8x | 8.4x |
| Wed, 29 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.4x | 37.1x | 8x |
| Fri, 27 May 2022 | ₹1.2t | ₹149.6b | ₹34.0b | 31.6x | 36x | 8.2x |
| Sun, 24 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 36.6x | 52.5x | 10.4x |
| Tue, 22 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35x | 51.8x | 10.2x |
| Thu, 17 Feb 2022 | ₹1.5t | ₹148.2b | ₹29.4b | 36x | 51.8x | 10.3x |
| Sat, 15 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 40.5x | 65x | 11.6x |
| Mon, 13 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 30.5x | 63.1x | 11.3x |
| Wed, 10 Nov 2021 | ₹1.6t | ₹134.6b | ₹23.6b | 25.2x | 68x | 11.9x |
| Fri, 08 Oct 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 23.1x | 73.8x | 12.9x |
| Sun, 05 Sep 2021 | ₹1.7t | ₹131.4b | ₹22.9b | 24.9x | 74.5x | 13x |
| Tue, 03 Aug 2021 | ₹1.7t | ₹127.1b | ₹22.6b | 40.6x | 73.1x | 13x |
| Fri, 07 May 2021 | ₹1.4t | ₹121.4b | ₹21.5b | 40.3x | 63.4x | 11.2x |
Price to Earnings Ratio
63.4x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 76.4x which is higher than its 3-year average PE of 56.2x.
- The industry is trading close to its 3-year average PS ratio of 9.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 4.7% per year over the last three years.
- Meanwhile revenues for these companies have grown 12% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -2.09% | |
| Healthcare | -2.01% | |
| Life Sciences | -0.40% | |
| Clinical Research and Equipment | -0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INNOVACAP Innova Captab | ₹478.35 | 1.7% +₹457.8m | n/a | PE33x | |
| TARSONS Tarsons Products | ₹449.35 | 1.2% +₹290.2m | -15.1% | PE43.8x | |
| 540729 Vanta Bioscience | ₹66.50 | 3.9% +₹15.8m | 20.9% | PS4.1x | |
| 539267 Samsrita Labs | ₹16.66 | 3.6% +₹8.6m | -14.0% | PS1136.9x | |
| 511509 Vivo Bio Tech | ₹44.98 | 0.1% +₹894.2k | 85.3% | PE17.4x |
